Results for
"[search-keyword]"
Sponsor content
310 result(s) found, displaying 111 to 120
-
Designation or determinationProvisional determination
-
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ESOPREZE esomeprazole 40 mg (as magnesium trihydrate) tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ESOPREZE esomeprazole 20 mg (as magnesium trihydrate) tablet blister pack.
-
Australian Public Assessment Report (AusPAR)New AusPAR for EVUSHELD (tixagevimab and cilgavimab) for pre-exposure prophylaxis of COVID-19 in adults and adolescents aged 12 years older
-
Prescription medicine decision summaryTGA decision: Evusheld (tixagevimab/cilgavimab) is approved for the treatment of pre-exposure prophylaxis of COVID-19.
-
Prescription medicine registrationActive ingredients: cilgavimab; tixagevimab.
-
Prescription medicine registrationActive ingredients: cilgavimab; tixagevimab.
-
Australian Public Assessment Report (AusPAR)New AusPAR for Vaxzevria (ChAdOx-1-S) for the prevention of COVID-19 caused by SARS-CoV-2